KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Long-Term Debt Issuances (2020)

Historic Long-Term Debt Issuances for Aquestive Therapeutics (AQST) over the last 1 years, with Q4 2020 value amounting to $50.0 million.

  • Aquestive Therapeutics' Long-Term Debt Issuances changed N/A to $50.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $50.0 million, marking a year-over-year change of. This contributed to the annual value of $31.1 million for FY2023, which is N/A changed from last year.
  • Per Aquestive Therapeutics' latest filing, its Long-Term Debt Issuances stood at $50.0 million for Q4 2020.
  • In the past 5 years, Aquestive Therapeutics' Long-Term Debt Issuances registered a high of $50.0 million during Q4 2020, and its lowest value of $50.0 million during Q4 2020.